SCHEMBL18655377

SCHEMBL18655377

COc1cc(C2=C(c3cn(CCOC(=O)C(N)CC(C)C)c4ccccc34)C(=O)NC2=O)cc(O)c1OC

nearest known ligand 0.91

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 13/20 0.91
KDR P35968 12/20 0.91
FLT3 P36888 8/20 0.91
QPCT Q16769 1/20 0.46
PRKCA P17252 1/20 0.45
FLT4 P35916 2/20 0.45
TEK Q02763 2/20 0.45
PTK2 Q05397 2/20 0.45
PLK4 O00444 1/20 0.45
AURKA O14965 1/20 0.45
SRC P12931 1/20 0.45
PRKACA P17612 2/20 0.44
PRKACG P22612 2/20 0.44
PRKACB P22694 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18655373 0.95 GSK3B (0.91) GSK3BKDRFLT3QPCT
SCHEMBL9956127 0.95 KDR (1.00) GSK3BKDRFLT3QPCTPRKCA
SCHEMBL9955798 0.91 GSK3B (1.00) GSK3BKDRFLT3QPCTFLT4
SCHEMBL18655378 0.89 GSK3B (0.86) GSK3BKDRFLT3QPCT
SCHEMBL19070784 0.85 GSK3B (0.81) GSK3BKDRFLT3QPCTPRKCA
SCHEMBL22334761 0.85 KDR (0.81) GSK3BKDRFLT3FLT4TEK
SCHEMBL18655374 0.83 GSK3B (0.87) GSK3BKDRFLT3QPCTPRKCA
SCHEMBL10069744 0.82 GSK3B (1.00) GSK3BKDRFLT3QPCTFLT4
SCHEMBL19090416 0.81 GSK3B (0.82) GSK3BKDRFLT3QPCTFLT4
SCHEMBL18655372 0.81 GSK3B (0.80) GSK3BKDRFLT3QPCTFLT4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2655359-B1 CONJUGATED 3-(INDOLYL)- AND 3-(AZAINDOLYL)-4-ARYLMALEIMIDE COMPOUNDS AND THEIR USE IN TUMOR TREATMENT Johannes-Gutenberg-Universität Mainz (DE) 2017-03-22 EP disclosed